Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Delic Holdings Corp (DELCF) Message Board

Research Shows Psychedelics May Amplify Brain-Stim

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 135
(Total Views: 184)
Posted On: 07/10/2023 5:11:13 PM
Avatar
Posted By: NetworkNewsWire
Research Shows Psychedelics May Amplify Brain-Stimulation Effects

Psychedelics have enjoyed significant public interest in recent years due to their purported medical benefits. As more regions in the United States and across the world loosened psychedelic restrictions, initial research on psychedelics found that these substances could treat various mental disorders with fewer side effects.

This initial research opened the flood and led to the investment of millions of dollars into psychedelic research worldwide. Continued research has revealed that several psychedelics can be effective against a multitude of mental disorders, offering sustained and long-term relief at relatively minimal doses.

Scientists have been especially interested in how psychedelics affect brain chemistry and allow people to leave depressive states. Although most psychedelic research is still in its infancy, it has been found that psychedelic-assisted therapy, or the combination of psychedelics and talk therapy, is the most effective at treating mental conditions.

New research has found that LSD triggers changes in the brain by changing the effects of brain stimulation, allowing the psychedelic to produce various effects on an even larger scale. The research suggests that hallucinogenics could be used to develop various novel ways of treating a laundry list of health conditions.

One way that psychedelics deliver their benefits is by inducing neuroplasticity. This refers to the brain’s ability to reorganize and create new neural connections in response to stimuli. Psychedelics also induce changes by interacting with the serotonin 2A receptor to influence perception, cognition and mood.

The combination of enhancing neuroplasticity and interacting with receptors in the brain may be the reason why psychedelics provide long-term relief against conditions such as anxiety, depression and PTSD.

Lucas Dwiel, a study author and postdoctoral fellow at the Doucette Lab at the Geisel School of Medicine at Dartmouth, explained that while conventional treatments such as transcranial magnetic stimulation (TMS) may be effective against a wide range of psychiatric conditions, they rarely provide long-term relief. Dwiel said that using psychedelics such as LSD to make the brain easily susceptible to change would prolong the relief period and make psychiatric treatment more effective for plenty of patients.

His research team used rat models to measure changes in brain activity after administering LSD and analyzed the effects of combining LSD with brain stimulation. The team found that stimulating the brain 24 hours after administering a dose of LSD resulted in a state where the brain was susceptible to external interventions. Their results indicate that LSD may play a role in causing brain changes that come to the fore when the brain is stimulated.

Further studies are needed to fully understand the connection between LSD and brain stimulation, and this connection could be used to develop novel psychedelic treatments.

Further studies are also being conducted by various psychedelic industry players such as Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) to establish other ways through which these substances can be leveraged to treat a variety of conditions, including major depressive disorder.

NOTE TO INVESTORS: The latest news and updates relating to Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) are available in the company’s newsroom at https://ibn.fm/DELCF

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer




(0)
(0)




Delic Holdings Corp (DELCF) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us